Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Sep 9, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Sep 7, 2024 | Horse | Warmblood - Dutch | MSK | Dependent oedema; Hair loss NOS; Colic; Dehydration; Not eating; Pawing; Beha... | Outcome Unknown |
| Sep 6, 2024 | Horse | Warmblood (unspecified) | MSK | Hepatitis | Recovered/Normal |
| Sep 6, 2024 | Horse | Crossbred Equine/horse | MSK | Swollen mouth | Outcome Unknown |
| Sep 6, 2024 | Horse | Morgan | MSK | Neurological signs NOS; Muscle atrophy (see also Muscle wasting); Weakness | Outcome Unknown |
| Sep 5, 2024 | Horse | Irish Cob (Tinker) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 5, 2024 | Horse | Pura Raza Española (Andalus... | MSK | Anorexia; Diarrhoea; Weight loss | Outcome Unknown |
| Sep 4, 2024 | Horse | Missouri Fox Trotting Horse | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Sep 3, 2024 | Horse | Appaloosa | MSK | Diarrhoea; Gastric irritation | Recovered/Normal |
| Sep 3, 2024 | Horse | Paint | MSK | Death by euthanasia; Lack of efficacy (protozoa) - NOS | Euthanized |
| Sep 2, 2024 | Horse | Arab | MSK | Lying down; Colic | Recovered/Normal |
| Sep 2, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin); Itching; Pawing; Restlessness | Outcome Unknown |
| Sep 2, 2024 | Horse | Quarter Horse | MSK | Hyperventilation; Tachycardia; Ataxia; Increased sweating; Heavy breathing; F... | Recovered/Normal |
| Aug 31, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Aug 30, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Aug 30, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Aug 30, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Aug 30, 2024 | Horse | Quarter Horse | MSK | Application site swelling; Agitation; Head bobbing; Lip smacking; Tongue diso... | Recovered/Normal |
| Aug 29, 2024 | Horse | Thoroughbred | MSK | Shaking; Increased sweating; Injection site pain; Injection site swelling; In... | Recovered/Normal |
| Aug 29, 2024 | Horse | Horse (other) | MSK | Stumbling gait; Cyanotic mucous membranes; Death; Anaphylaxis | Died |
| Aug 27, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Aug 27, 2024 | Horse | Mustang | MSK | Immediate pain upon injection; Injection site reaction NOS; Excessive defensi... | Recovered/Normal |
| Aug 26, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin); Oedema NOS (see other SOCs for specific oedemas); Skin... | Ongoing |
| Aug 22, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Aug 22, 2024 | Horse | Morgan, Morgan | MSK | Injection site alopecia | Recovered/Normal |
| Aug 22, 2024 | Horse | Crossbred Equine/horse, Morgan | MSK | Recumbency; Behavioural disorder NOS | Recovered/Normal |
| Aug 21, 2024 | Horse | Holsteiner | MSK | Trembling; Injection site pain | Recovered/Normal |
| Aug 21, 2024 | Horse | Holsteiner | MSK | Trembling; Injection site pain | Recovered/Normal |
| Aug 21, 2024 | Horse | Pony (unspecified) | MSK | Injection site swelling; Injection site pain | Ongoing |
| Aug 21, 2024 | Horse | Horse (unknown) | MSK | Sudden death; Accidental exposure | Died |
| Aug 20, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy (virus) - rotavirus | Outcome Unknown |
| Aug 19, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin); Hypersensitivity reaction | Ongoing |
| Aug 19, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Aug 19, 2024 | Horse | Warmblood (unspecified) | MSK | Lethargy (see also Central nervous system depression in Neurological); Anorexia | Recovered/Normal |
| Aug 19, 2024 | Horse | Welsh Pony | MSK | Injection site swelling; Behavioural disorder NOS; Irritability; Agitation; G... | Ongoing |
| Aug 19, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Aug 16, 2024 | Horse | Warmblood (unspecified) | MSK | Death by euthanasia; Lack of efficacy - NOS | Euthanized |
| Aug 16, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Aug 15, 2024 | Horse | Trakehner | MSK | Muscle stiffness; Fasciculation | Recovered/Normal |
| Aug 15, 2024 | Horse | Warmblood (unspecified) | MSK | Death by euthanasia; Diarrhoea; Inappetence; Digestive tract hypermotility; I... | Euthanized |
| Aug 15, 2024 | Horse | Arab | MSK | Lack of efficacy - NOS | Ongoing |
| Aug 15, 2024 | Horse | Hanovarian, Paint | MSK | Injection site hair change; Injection site hair loss; Injection site reddenin... | Recovered/Normal; Outcome Unknown |
| Aug 14, 2024 | Horse | Friesian | MSK | Lack of efficacy - NOS | Ongoing |
| Aug 13, 2024 | Horse | Warmblood - Dutch | MSK | Polyuria; Polydipsia; Quiet; Lethargy (see also Central nervous system depres... | Ongoing |
| Aug 13, 2024 | Horse | Unknown | MSK | Lack of efficacy - NOS; Death by euthanasia; Abnormal breathing | Euthanized |
| Aug 13, 2024 | Horse | Horse (unknown) | MSK | Injection site swelling; Intentional misuse | Ongoing |
| Aug 13, 2024 | Horse | Warmblood - Dutch | MSK | Polyuria; Polydipsia; Quiet; Lethargy (see also Central nervous system depres... | Outcome Unknown |
| Aug 13, 2024 | Horse | Quarter Horse | MSK | Injection site swelling | Outcome Unknown |
| Aug 12, 2024 | Horse | Quarter Horse | MSK | Hives (see also Skin) | Outcome Unknown |
| Aug 12, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.